Rethinking bronchiectasis as an inflammatory disease
The Lancet Respiratory Medicine,
Journal Year:
2024,
Volume and Issue:
12(11), P. 901 - 914
Published: July 3, 2024
Language: Английский
Increased risk of obstructive lung disease in inflammatory bowel disease: A population‐based cohort study
United European Gastroenterology Journal,
Journal Year:
2024,
Volume and Issue:
12(4), P. 477 - 486
Published: Jan. 6, 2024
Abstract
Background
and
Aims
Inflammatory
bowel
disease
(IBD)
is
associated
with
manifestations
in
organs
other
than
the
gastrointestinal
tract.
In
this
study,
we
aimed
to
estimate
odds
of
obstructive
lung
(OLD)
before
IBD
onset
risk
OLD
after
onset.
Methods
a
nationwide
population‐based
Danish
cohort
study
from
1999
2018,
individuals
were
identified
using
registries.
Between
2003
2013,
24,238
matched
1:10
non‐IBD
individuals.
Logistic
regression
was
used
prevalence
ratio
for
Time‐to‐event
analysis
performed
explore
sensitivity
analysis,
time‐to‐event
repeated
composite
outcome
separate
outcomes,
chronic
pulmonary
(COPD),
asthma,
bronchiectasis.
Results
Individuals
60%
more
likely
have
(adjusted
ratio:
1.60,
95%
confidence
interval
[CI]:
1.53–1.67).
Furthermore,
their
40%
higher
diagnosis
hazard
[aHR]:
1.43,
CI:
1.37–1.49).
The
increased
(aHR:
1.63,
1.53–1.73).
Similar
results
found
COPD
asthma
separately,
whereas
bronchiectasis
2‐fold
2.44,
1.91–3.11).
Conclusion
before‐
following
an
increased.
We
encourage
physicians
be
vigilant
symptoms
persons
OLD.
Language: Английский
Bidirectional association between asthma and inflammatory bowel disease: a systematic review and meta-analysis
Yuyue Jiang,
No information about this author
Xuqing Huang,
No information about this author
Yan Wang
No information about this author
et al.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
2(1)
Published: March 12, 2025
Language: Английский
Thirty-day outcomes of non-emergent colectomy for inflammatory bowel disease in patients with chronic obstructive pulmonary disease
Renxi Li
No information about this author
Clinics and Research in Hepatology and Gastroenterology,
Journal Year:
2024,
Volume and Issue:
48(8), P. 102445 - 102445
Published: Aug. 6, 2024
Language: Английский
Increased risk of chronic respiratory disease among individuals with inflammatory bowel disease in a prospective cohort study
Lintao Dan,
No information about this author
Ying Xie,
No information about this author
Tian Fu
No information about this author
et al.
The American Journal of Medicine,
Journal Year:
2024,
Volume and Issue:
138(1), P. 42 - 50.e5
Published: Oct. 5, 2024
Language: Английский
Simultaneous treatment with benralizumab and ustekinumab in a patient with severe asthma and ulcerative colitis
Lorenzo Carriera,
No information about this author
Roberto Barone,
No information about this author
Simone Ielo
No information about this author
et al.
Lung India,
Journal Year:
2024,
Volume and Issue:
42(1), P. 49 - 52
Published: Dec. 24, 2024
The
burden
of
autoimmune
diseases
is
rising
worldwide.
expansion
the
population
patients
eligible
for
severe
asthma
biological
therapy
we
are
seeing
in
clinical
practice
could
lead
to
simultaneous
use
different
monoclonal
antibodies.
We
present
case
combination
with
ustekinumab
and
benralizumab
a
patient
ulcerative
colitis
eosinophilic
asthma.
patient,
already
undergoing
treatment
colitis,
began
suffer
from
uncontrolled
Since
was
administered,
has
not
experienced
any
exacerbations
requiring
oral
corticosteroids,
emergency
department
visits,
or
hospital
admissions,
control
symptoms
respiratory
function
considerably
improved.
Twelve
months
after
initiation
combination,
both
well
controlled,
without
side
effects
blood
test
abnormalities.
To
our
knowledge,
this
one
first
reported
cases
simultaneously
receiving
Language: Английский